EMBC_MYCSM
ID EMBC_MYCSM Reviewed; 1074 AA.
AC Q50393;
DT 23-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT 01-JUL-1997, sequence version 2.
DT 25-MAY-2022, entry version 89.
DE RecName: Full=Probable arabinosyltransferase C;
DE EC=2.4.2.-;
GN Name=embC;
OS Mycolicibacterium smegmatis (Mycobacterium smegmatis).
OC Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC Mycolicibacterium.
OX NCBI_TaxID=1772;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=imm30;
RX PubMed=9142129; DOI=10.1038/nm0597-567;
RA Telenti A., Philipp W.J., Sreevatsan S., Bernasconi C., Stockbauer K.E.,
RA Wieles B., Musser J.M., Jacobs W.R. Jr.;
RT "The emb operon, a gene cluster of Mycobacterium tuberculosis involved in
RT resistance to ethambutol.";
RL Nat. Med. 3:567-570(1997).
CC -!- FUNCTION: Arabinosyl transferase responsible for the polymerization of
CC arabinose into the arabinan of arabinogalactan.
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass membrane
CC protein {ECO:0000305}.
CC -!- MISCELLANEOUS: This is one of the targets of the anti-tuberculosis drug
CC ethambutol [(S,S')-2,2'-(ethylenediimino)di-1-butanol; EMB]. EMB is a
CC first-line drug used to treat tuberculosis. EMB inhibits the transfer
CC of arabinogalactan into the cell wall.
CC -!- SIMILARITY: Belongs to the emb family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; U46844; AAC45271.1; -; Genomic_DNA.
DR PIR; T45094; T45094.
DR AlphaFoldDB; Q50393; -.
DR SMR; Q50393; -.
DR CAZy; GT53; Glycosyltransferase Family 53.
DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR GO; GO:0052636; F:arabinosyltransferase activity; IEA:InterPro.
DR GO; GO:0071766; P:Actinobacterium-type cell wall biogenesis; IEA:InterPro.
DR GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR Gene3D; 2.60.120.610; -; 1.
DR Gene3D; 2.60.120.940; -; 1.
DR InterPro; IPR032731; Arabino_trans_C.
DR InterPro; IPR042486; Arabino_trans_C_2.
DR InterPro; IPR007680; Arabino_trans_central.
DR InterPro; IPR040920; Arabino_trans_N.
DR InterPro; IPR027451; EmbABC_dom1.
DR Pfam; PF14896; Arabino_trans_C; 1.
DR Pfam; PF17689; Arabino_trans_N; 1.
DR Pfam; PF04602; Arabinose_trans; 1.
PE 3: Inferred from homology;
KW Antibiotic resistance; Cell membrane; Cell wall biogenesis/degradation;
KW Glycosyltransferase; Membrane; Transferase; Transmembrane;
KW Transmembrane helix.
FT CHAIN 1..1074
FT /note="Probable arabinosyltransferase C"
FT /id="PRO_0000220572"
FT TRANSMEM 15..37
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 214..236
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 251..273
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 415..437
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 452..474
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 516..538
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 573..595
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 608..630
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 645..667
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 684..706
FT /note="Helical"
FT /evidence="ECO:0000255"
SQ SEQUENCE 1074 AA; 115392 MW; 68DB19FE8839C301 CRC64;
MTGPHAAGGS NHRTARLVAI IAGLLGTLMA IATPLLPVEQ TTAELNWPQN GVWQSVDAPL
IGYVATDLTV TVPCQAAAGL VGPENRNRSV LLSTVPKQAP KAIDRGLLIE RINNDLTVIV
RNTPVVSAPL EQVLSPDCRY LTFTAHADKV TGEFVGLTQG PDDDDPGEAV RGERSGYDFR
PQIVGVFTDL SGPAPEGLQL SATIDTRYST SPTLLKLLAM IVGVAMTVIA LGALHVLDCA
DGRRHKRFLP SRWWSMTPLD GLVSAMLVWW HFVGANTADD GYILTMARVS EHAGYMANYY
RWFGTPESPF GWYYDLLALW AHVSTASVWM RFPTLLMGLA CWWVISREVI PRLGAAAKHS
RAAAWTAAGL FLAFWLPLNN GLRPEPIIAL GILLTWCSVE RGVATSRLLP VAVAIIIGAL
TLFSGPTGIA AVGALLVAIG PLKTIVAAHV SRFGYWALLA PIAAAGTVTI FLIFRDQTLA
AELQASSFKS AVGPSLAWFD EHIRYSRLFT TSPDGSVARR FAVLTLLLAL AVSIAMTLRK
GRIPGTALGP SRRIIGITII SFLAMMFTPT KWTHQFGVFA GLAGCLGALA AVAVTTTAMK
SRRNRTVFGA AVLFVTALSF ATVNGWWYVS NFGVPWSNSF PEFKFGFTTM LLGLSVLALL
VAAWFHFSGR DVSPDRPQRR WQRLLVAPLA VATWALVIFE VVSLTLGMIN QYPAWSVGRS
NLNALTGKTC GLANDVLVEQ NANAGMLTPI GEPAGQALGA VTSLGFGPNG IPSDVSADPV
MEQPGTDNFA DSDSGVVTGT EVGTEGGTTA AAGINGSRAR LPYGLNPATT PVLGSWRSGT
QQPAVLRSAW YRLPDRDQAG PLLVVSAAGR FDQGEVEVQW ATDEQAAANE PGGSITFGDV
GAAPAWRNLR APLSSIPPEA TQIRLVASDD DLAPQHWIAL TPPRIPELRT LQEVVGSSDP
VMLDWLVGLA FPCQRPFDHR YGVVEVPKWR ILPDRFGAEA NSPVMDYLGG GPLGITELLL
RPSSVPTYLK DDWYRDWGSL QRLTPWYPDA QPARLDLGTA TRSGWWSPAP LRLS